Have a personal or library account? Click to login
Clinical Practice Patterns in Tic Disorders Among Movement Disorder Society Members Cover

Clinical Practice Patterns in Tic Disorders Among Movement Disorder Society Members

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Christos Ganos,  Harini Sarva,  Lille Kurvits,  Donald L. Gilbert,  Andreas Hartmann,  Yulia Worbe,  Pablo Mir,  Kirsten R. Müller-Vahl,  Alexander Münchau,  David Shprecher,  Harvey S. Singer,  Wissam Deeb,  Michael S. Okun,  Irene A. Malaty,  Mark Hallett,  Marina AJ Tijssen,  Tamara Pringsheim and  Davide Martino  
Open Access
|Oct 2021

References

  1. 1Ganos C, Martino D. Tics and tourette syndrome. Neurol Clin. 2015; 33(1): 115–36. DOI: 10.1016/j.ncl.2014.09.008
    Back to article
  2. 2Knight T, et al. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatric neurology, 2012; 47(2): 77–90. DOI: 10.1016/j.pediatrneurol.2012.05.002
    Back to article
  3. 3American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 2013, Arlington, VA: American Psychiatric Publishing. DOI: 10.1176/appi.books.9780890425596
    Back to article
  4. 4Roessner V, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. European child & adolescent psychiatry. 2011; 20(4): 173–96. DOI: 10.1007/s00787-011-0163-7
    Back to article
  5. 5Pringsheim T, et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2012. 57(3): 133–43. DOI: 10.1177/070674371205700302
    Back to article
  6. 6Pringsheim T, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019; 92(19): 896–906. DOI: 10.1212/WNL.0000000000007466
    Back to article
  7. 7Bhikram T, et al. An International Survey of Health Care Services Available to Patients With Tourette Syndrome. Front Psychiatry. 2021; 12: 621874. DOI: 10.3389/fpsyt.2021.621874
    Back to article
  8. 8Harris PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. DOI: 10.1016/j.jbi.2019.103208
    Back to article
  9. 9Harris PA, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009. 42(2): 377–81. DOI: 10.1016/j.jbi.2008.08.010
    Back to article
  10. 10Martino D, et al. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord. 2017; 32(3): 467–473. DOI: 10.1002/mds.26891
    Back to article
  11. 11Longardner K, et al. Photosensitive Epilepsy Syndromes Mimicking Motor Tics. Mov Disord Clin Pract. 2020; 7(Suppl 3): S89–S92. DOI: 10.1002/mdc3.13053
    Back to article
  12. 12Martino D, et al. Association of Group A Streptococcus Exposure and Exacerbations of Chronic Tic Disorders: A Multinational Prospective Cohort Study. Neurology. 2021; 96(12): e1680–e1693.
    Back to article
  13. 13Heyman I, Liang H, Hedderly T. COVID-19 related increase in childhood tics and tic-like attacks. Arch Dis Child; 2021. DOI: 10.1136/archdischild-2021-321748
    Back to article
  14. 14Demartini B, et al. A positive diagnosis of functional (psychogenic) tics. Eur J Neurol. 2015; 22(3): 527–e36. DOI: 10.1111/ene.12609
    Back to article
  15. 15Baizabal-Carvallo JF, Jankovic J. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry. 2014; 85(5): 573–5. DOI: 10.1136/jnnp-2013-305594
    Back to article
  16. 16Ganos C, Edwards MJ, Muller-Vahl K. “I swear it is Tourette’s!”: On functional coprolalia and other tic-like vocalizations. Psychiatry Res. 2016; 246: 821–826. DOI: 10.1016/j.psychres.2016.10.021
    Back to article
  17. 17Ganos C, et al. Tics and functional tic-like movements: Can we tell them apart? Neurology. 2019; 93(17): 750–758. DOI: 10.1212/WNL.0000000000008372
    Back to article
  18. 18Leckman JF, Riddle MA. Tourette’s syndrome: when habit-forming systems form habits of their own? Neuron. 2000; 28(2): 349–54. DOI: 10.1016/S0896-6273(00)00114-8
    Back to article
  19. 19Bronfeld M, et al. Motor tics evoked by striatal disinhibition in the rat. Frontiers in systems neuroscience. 2013; 7: 50. DOI: 10.3389/fnsys.2013.00050
    Back to article
  20. 20Ganos C, et al. The Phenomenon of Exquisite Motor Control in Tic Disorders and its Pathophysiological Implications. Mov Disord; 2021. DOI: 10.1002/mds.28557
    Back to article
  21. 21Schrag A, et al. Streptococcal infection, Tourette syndrome, and OCD: is there a connection? Neurology. 2009; 73(16): 1256–63. DOI: 10.1212/WNL.0b013e3181bd10fd
    Back to article
  22. 22Orlovska S, et al. Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study. JAMA Psychiatry. 2017; 74(7): 740–746. DOI: 10.1001/jamapsychiatry.2017.0995
    Back to article
  23. 23Leslie DL, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry. 2008; 47(10): 1166–72. DOI: 10.1097/CHI.0b013e3181825a3d
    Back to article
  24. 24Kurlan R, et al. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics. 2008; 121(6): 1188–97. DOI: 10.1542/peds.2007-2657
    Back to article
  25. 25Rizzo R, et al. Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities. J Child Neurol. 2014; 29(10): 1383–9. DOI: 10.1177/0883073814534317
    Back to article
  26. 26Eddy CM, et al. The effects of comorbid obsessive-compulsive disorder and attention-deficit hyperactivity disorder on quality of life in tourette syndrome. J Neuropsychiatry Clin Neurosci. 2012; 24(4): 458–62. DOI: 10.1176/appi.neuropsych.11080181
    Back to article
  27. 27Cavanna AE, et al. Disease-specific quality of life in young patients with tourette syndrome. Pediatr Neurol. 2013; 48(2): 111–4. DOI: 10.1016/j.pediatrneurol.2012.10.006
    Back to article
  28. 28Fletcher J, Martino D, Pringsheim T. Novel Pharmacological Approaches for Tourette Syndrome. Current Developmental Disorders Reports. 2020; 7(4): 270–276. DOI: 10.1007/s40474-020-00213-x
    Back to article
  29. 29Mukaddes NM, Abali O. Quetiapine treatment of children and adolescents with Tourette’s disorder. J Child Adolesc Psychopharmacol. 2003; 13(3): 295–9. DOI: 10.1089/104454603322572624
    Back to article
  30. 30de Jonge JL, Cath DC, van Balkom AJ. Quetiapine in patients with Tourette’s disorder: an open-label, flexible-dose study. J Clin Psychiatry. 2007; 68(7): 1148–50. DOI: 10.4088/JCP.v68n0726e
    Back to article
DOI: https://doi.org/10.5334/tohm.656 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Aug 11, 2021
Accepted on: Sep 24, 2021
Published on: Oct 28, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Tic disorders,
Tourette disorder,
Survey,
Tic Disorders and Tourette Syndrome Study Group,
Movement Disorder Society

© 2021 Christos Ganos, Harini Sarva, Lille Kurvits, Donald L. Gilbert, Andreas Hartmann, Yulia Worbe, Pablo Mir, Kirsten R. Müller-Vahl, Alexander Münchau, David Shprecher, Harvey S. Singer, Wissam Deeb, Michael S. Okun, Irene A. Malaty, Mark Hallett, Marina AJ Tijssen, Tamara Pringsheim, Davide Martino, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article